The CaMKII D135N mutation blocks kinase activity and reduces GluN2B binding

Read full text
Authors: Matthew E. Larsen, C. Madison Barker, Raul Satoshi Vargas, Steven J. Coultrap, Karl Ulrich Bayer
Cited by: 0
References: 33

Abstract

/Calmodulin(CaM)-dependent protein kinase II (CaMKII). One study utilized the CaMKII D135N mutation, which was claimed to abolish enzymatic activity without affecting the structural function, i.e. binding to GluN2B. We found here that the D135N mutant indeed abolished enzymatic kinase activity and autophosphorylation at T286 (pT286). However, D135N mutation additionally reduced binding to GluN2B and prevented persistence of co-condensation with GluN2B. Similar as with the T286A mutant, GluN2B binding of the D135N mutant could be partially rescued by AS283, an inhibitor that directly enhances GluN2B binding. This partial effect on GluN2B binding has to be taken into account when using D135N to distinguish between enzymatic versus structural functions of CaMKII. Nonetheless, as discussed here, the D135N mutant indeed supports a structural rather than enzymatic CaMKII function in LTP induction.

Fields of Study & Subjects

Neuroscience and Neuropharmacology Research Ion channel regulation and function Receptor Mechanisms and Signaling

Publication details

Journal / source
Molecular Pharmacology
Volume
108
Issue
5-6
Pages
100127–100127
Publication date
1 May 2026
Language
EN